Mycoplasma Testing Market and Cell Therapy: Why Speed-to-Release Is the New Competitive Edge
The mycoplasma testing market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.8 billion by 2033, growing at a CAGR of 12.0% from 2026 to 2033. Mycoplasma are tiny bacteria that pass through standard filters and quietly contaminate cell cultures. Every biologic, vaccine, and cell therapy batch therefore needs documented proof that they are absent. That non-negotiable...
0 Commentarii 0 Distribuiri 12 Views